valproic acid has been researched along with prednisone in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.82) | 18.7374 |
1990's | 8 (23.53) | 18.2507 |
2000's | 14 (41.18) | 29.6817 |
2010's | 8 (23.53) | 24.3611 |
2020's | 1 (2.94) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Feng, Y | 1 |
Chung, EY; Rosenbaum, D; Van Woert, MH | 1 |
Swaiman, KF | 1 |
Hackett, T; Kelton, JG; Powers, P | 1 |
Casto, DT; Haines, ST | 1 |
Abbas, A; Styra, R | 1 |
Appleton, RE | 1 |
Louie, J; Oftadeh, LC; Oh, C; Song, CH; Yu, KT | 1 |
Aumaitre, O; Biousse, V; Bousser, MG; Fardeau, C; Godeau, P; Huong, DL; Lehoang, P; N'Guyen, N; Papo, T; Piette, JC | 1 |
Angelini, L; Besana, C; Binelli, S; Granata, T; Zibordi, F; Zorzi, G | 1 |
Bowers, MB; Fazeli, A; Mazure, CM; McKay, BG; Preda, A | 1 |
Antoniuk, SA; Bruck, I; de Bruyn, LR; de Paola, D; Halick, SM; Meister, E; Spessatto, A | 1 |
Bauret, P; Berthier, E; Blanc, F; Blayac, JP; Fabbro-Peray, P; Hanslik, B; Hillaire-Buys, D; Larrey, D; Melki, M; Pageaux, GP; Perney, P; Roques, V | 1 |
Berroya, AG; Bleasel, AF; Bye, AM; Lah, S; Lawson, J; McIntyre, J; Sabaz, M; Webster, R | 1 |
Chiarelli, F; Coppola, GG; Iannetti, P; Manco, R; Mingione, S; Verrotti, A | 1 |
Godoy, J; Mellado, P; Soler, B | 1 |
Aragão, I; Cardoso, T; Guedes, F; Maia, JM | 1 |
Drott, K; Hagberg, H; Jerkeman, M; Papworth, K; Relander, T | 1 |
Gan, J; Wang, J; Zhang, J | 1 |
7 review(s) available for valproic acid and prednisone
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Myoclonus.
Topics: Adrenocorticotropic Hormone; Child; Child, Preschool; Clonazepam; Diagnosis, Differential; Electroencephalography; Epilepsies, Myoclonic; Humans; Infant; Infant, Newborn; Myoclonus; Nitrazepam; Prednisone; Spasms, Infantile; Valproic Acid | 1985 |
Drug-induced platelet destruction.
Topics: Binding Sites, Antibody; Blood Platelets; Cell Differentiation; Cell Migration Inhibition; Clot Retraction; Complement Fixation Tests; Gold; Heparin; Humans; Immunoglobulin G; Intradermal Tests; Platelet Aggregation; Platelet Factor 3; Prednisone; Quinidine; Ristocetin; Serotonin; Thrombocytopenia; Thromboembolism; Urea; Valproic Acid | 1982 |
Treatment of infantile spasms.
Topics: 4-Aminobutyrate Transaminase; Adrenocorticotropic Hormone; Anticonvulsants; Benzodiazepines; gamma-Aminobutyric Acid; Humans; Infant; Infant, Newborn; Prednisone; Spasms, Infantile; Valproic Acid; Vigabatrin | 1994 |
Susac syndrome.
Topics: Adult; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Brain Diseases; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorescein Angiography; GABA Agents; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Methylprednisolone; Prednisone; Retinal Artery Occlusion; Syndrome; Valproic Acid | 1998 |
Update of the medical treatment of West syndrome.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Drug Therapy, Combination; Electroencephalography; Glucocorticoids; Humans; Infant; Prednisone; Spasms, Infantile; Treatment Outcome; Valproic Acid; Vigabatrin; Vitamin B 6 | 2007 |
3 trial(s) available for valproic acid and prednisone
Article | Year |
---|---|
Partial seizures associated with antiphospholipid antibodies in childhood.
Topics: Adolescent; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticonvulsants; Antiphospholipid Syndrome; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; Humans; Lupus Coagulation Inhibitor; Male; Prednisone; Valproic Acid | 1998 |
[West syndrome: clinical and electroencephalographic follow up of 70 patients and response to its treatment with adrenocorticotropic hormone, prednisone, vigabatrin, nitrazepam and valproate].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Nitrazepam; Prednisone; Retrospective Studies; Spasms, Infantile; Treatment Outcome; Valproic Acid; Vigabatrin | 2000 |
Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Histone Deacetylase Inhibitors; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Rituximab; Valproic Acid; Vincristine | 2018 |
24 other study(ies) available for valproic acid and prednisone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Infantile spasms. A retrospective study of 105 cases].
Topics: Adrenocorticotropic Hormone; Child; Child, Preschool; Electroencephalography; Evoked Potentials, Auditory, Brain Stem; Female; Humans; Infant; Infant, Newborn; Male; Prednisone; Retrospective Studies; Spasms, Infantile; Tomography, X-Ray Computed; Valproic Acid | 1992 |
Biochemistry and therapeutics of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Aspartic Acid; Benzodiazepines; Carbidopa; Electroencephalography; gamma-Aminobutyric Acid; Glycine; Humans; Hydroxyindoleacetic Acid; Hypoxia; Methysergide; Models, Biological; Myoclonus; Prednisone; Serotonin; Tryptophan; Valproic Acid | 1986 |
Valproate prophylaxis against steroid induced psychosis.
Topics: Adult; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Methylprednisolone; Optic Neuritis; Prednisone; Psychoses, Substance-Induced; Valproic Acid | 1994 |
The treatment of infantile spasms by paediatric neurologists in the UK and Ireland.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Anticonvulsants; gamma-Aminobutyric Acid; Humans; Infant; Infant, Newborn; Ireland; Neurology; Pediatrics; Pituitary Hormones; Prednisone; Pyridoxine; Spasms, Infantile; Surveys and Questionnaires; United Kingdom; Valproic Acid; Vigabatrin; Workforce | 1996 |
Successful treatment of steroid-resistant chorea associated with lupus by use of valproic acid and clonidine-HCL patch.
Topics: Administration, Oral; Adolescent; Chorea; Clonidine; Female; Humans; Injections, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Prednisone; Valproic Acid | 1997 |
Lamotrigine as prophylaxis against steroid-induced mania.
Topics: Adult; Anti-Inflammatory Agents; Antimanic Agents; Bipolar Disorder; Contraindications; Female; Humans; Lamotrigine; Lithium; Nephritis, Interstitial; Prednisone; Triazines; Valproic Acid | 1999 |
Are drugs a risk factor of post-ERCP pancreatitis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Cholangiopancreatography, Endoscopic Retrograde; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Humans; Male; Mesalamine; Middle Aged; Morphine Derivatives; Multivariate Analysis; Pancreatitis; Prednisone; Retrospective Studies; Risk Factors; Valproic Acid | 2003 |
Speech and language deterioration in benign rolandic epilepsy.
Topics: Anomia; Anticonvulsants; Carbamazepine; Cerebral Cortex; Child; Child, Preschool; Cognition Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dysarthria; Electroencephalography; Epilepsy, Rolandic; Ethosuximide; Evoked Potentials; Follow-Up Studies; Humans; Language Development Disorders; Male; Neuropsychological Tests; Prednisone; Speech Perception; Treatment Outcome; Valproic Acid; Verbal Learning | 2004 |
[Limbic encephalitis associated to voltage dependent potassium channel antibodies: report of one case].
Topics: Aged; Autoantibodies; Electroencephalography; Glucocorticoids; Humans; Levetiracetam; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Piracetam; Potassium Channels, Voltage-Gated; Prednisone; Tomography, X-Ray Computed; Valproic Acid | 2009 |
Eosinophilic pneumonia presenting as life-threatening ARDS.
Topics: Adult; Alprazolam; Antidepressive Agents, Second-Generation; Caustics; Cough; Drug Therapy, Combination; Eosinophilia; Eosinophils; Female; Glucocorticoids; Humans; Lye; Paroxetine; Prednisone; Pulmonary Eosinophilia; Radiography, Thoracic; Respiratory Distress Syndrome; Suicide, Attempted; Treatment Outcome; Valproic Acid | 2015 |
A case of GFAP-IgG positivity followed by anti-NMDAR encephalitis.
Topics: Acyclovir; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Child; Encephalitis; Female; Hashimoto Disease; Humans; Immunoglobulin G; Methylprednisolone; Neoplasm Recurrence, Local; Prednisone; Seizures; Syndrome; Valproic Acid | 2022 |